Laatste proeven

EudraCT Number: 2006-003762-33 Sponsor Protocol Number: 106481 Start Date: 2006-12-06
Sponsor Name: GlaxoSmithKline Biologicals
Full Title: A phase IIIb, double blind, randomised, placebo–controlled, multi–country, multicentre study to assess the safety, reactogenicity and immunogenicity of two doses of GlaxoSmithKline (GSK) Biological...
Medical condition: Primary immunisation of pre–term infants against human rotavirus gastroenteritis (GE)
Disease: Version SOC Term Classification Code Term Level
Population Age: Preterm newborn infants, Under 18 Gender: Male, Female
Trial protocol: FR (Completed) PT (Completed) ES (Completed)
Trial results: View results
EudraCT Number: 2006-004815-24 Sponsor Protocol Number: FM-MYEL-06-01 Start Date: 2006-12-05
Sponsor Name: FONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI
Full Title: Bortezomib and dexamethasone treatment before donor lymphocyte infusions for myeloma patients progressing or relapsing after allogeneic transplantation of hematopoietic cells
Medical condition: Myeloma patients progressing or relapsing after allogeneic transplantation
Disease: Version SOC Term Classification Code Term Level
9.1 10028228 Multiple myeloma LLT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2006-003785-33 Sponsor Protocol Number: 20060100 Start Date: 2006-12-05
Sponsor Name: Amgen Inc
Full Title: A Global, Multicenter, Open-label, Single Agent, Two-stage Phase 2 Study to Evaluate the Efficacy and Safety of AMG 102 in Subjects With Advanced Renal Cell Carcinoma
Medical condition: Advanced Renal Cell Carcinoma
Disease: Version SOC Term Classification Code Term Level
8.1 10050513 Metastatic renal cell carcinoma LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: BE (Completed)
Trial results: View results
EudraCT Number: 2006-001276-20 Sponsor Protocol Number: USA107212 Start Date: 2006-12-05
Sponsor Name: GlaxoSmithKline GmbH & Co. KG
Full Title: A randomized, open-label, multicenter, parallel-group study to compare the efficacy, safety and resource utilization of a remifentanil/propofol analgosedation regimen versus a sufentanyl/propofol a...
Medical condition: Ventilated patients under intensive medical care with an expected duration of analgosedation of up to 7 days
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Prematurely Ended)
Trial results: View results
EudraCT Number: 2005-004287-23 Sponsor Protocol Number: P04592 Start Date: 2006-12-05
Sponsor Name: Schering Plough Research Institute, a division of Schering Corporation
Full Title: Safety and Dose-Ranging Study of the Effects of SCH 527123 in Subjects With Moderate to Severe COPD
Medical condition: Chronic Obstructive Pulmonary Disease
Disease: Version SOC Term Classification Code Term Level
8.1 10009033 Chronic obstructive pulmonary disease LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Prematurely Ended)
Trial results: View results
EudraCT Number: 2006-002286-40 Sponsor Protocol Number: 1-1 Start Date: 2006-12-05
Sponsor Name: Pfizer bv
Full Title: Chronic Pain Management after Herniorraphy Pregabaline versus Placebo
Medical condition: Patients suffering from chronic pain of neuropathic character after open hernia repair.
Disease: Version SOC Term Classification Code Term Level
8.1 10049475 Chronic pain LLT
Population Age: Adults, Elderly Gender: Male
Trial protocol: NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2005-005460-80 Sponsor Protocol Number: JMV001 Start Date: 2006-12-05
Sponsor Name: N/A
Full Title: A single center, randomized, open-label, comparative study to assess efficacy and safety of piracetam 4.8g/d administered for 6 months as adjuvant to standard vestibular rehabilitation (VR) therapy...
Medical condition: moderate to severe vertigo of peripheral origin
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: GR (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-003096-12 Sponsor Protocol Number: CMN/ELA Start Date: 2006-12-05
Sponsor Name: FUNDACIÓN PARA LA FORMACIÓN E INVESTIGACIÓN SANITARIAS DE LA REGIÓN DE MURCIA
Full Title: ENSAYO CLÍNICO EN FASE I/II DE UTILIZACIÓN DE LAS CÉLULAS MADRE DE MÉDULA ÓSEA AUTÓLOGAS EN PACIENTES CON ESCLEROSIS LATERAL AMIOTRÓFICA
Medical condition: ESCLEROSIS LATERAL AMIOTRÓFICA
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: (No results available)
EudraCT Number: 2006-006263-23 Sponsor Protocol Number: ML20910 Start Date: 2006-12-05
Sponsor Name: ROCHE
Full Title: Efficacy of Oseltamivir treatment in laboratory- confirmed influenza: evaluation of effect on viral shedding and on serum and cytoplasmatic inflammatory cytokine concentration.
Medical condition: Influenza type A and B virus infection
Disease: Version SOC Term Classification Code Term Level
14.1 10021881 - Infections and infestations 10022000 Influenza PT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2006-001367-36 Sponsor Protocol Number: DoxP-01/2006 Start Date: 2006-12-05
Sponsor Name: Prof. Dr. Peter Eickholz
Full Title: Benefit of adjunctive systemic postsurgical doxycycline in regenerative periodontal surgery
Medical condition: Periodontitis is an opportunistic infectious disease that destroys the periodontal attachment and bone. Bacterial plaque (biofilm) on the teeth adjacent to the gingiva is the necessary cause gingiv...
Disease: Version SOC Term Classification Code Term Level
8.1 10034539 Periodontitis LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: (No results available)

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren